Precision Medicine: Clinical Tolerance to Hyperfibrinolysis Differs by Shock and Injury Severity

Ann Surg. 2022 Mar 1;275(3):e605-e607. doi: 10.1097/SLA.0000000000004548.

Abstract

The definition of hyperfibrinolysis based on thrombelastogram LY30 measurements should vary with trauma patient characteristics, i.e., as anatomic injury or shock severity increase, the ability to tolerate even mild degrees of fibrinolysis is markedly reduced. This trend is independent of institutional practice patterns. The management of hyperfibrinolysis, particularly with anti-fibrinolytics administration, should be interpreted in the context of injury severity/shock and managed on an individual patient basis.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Blood Coagulation Disorders / etiology*
  • Fibrinolysis
  • Humans
  • Injury Severity Score
  • Middle Aged
  • Precision Medicine*
  • Prospective Studies
  • Shock / etiology*
  • Wounds and Injuries / complications*